Diabetic peripheral neuropathic pain: Case studies

被引:3
|
作者
Belgrade, MJ
Cole, BE
McCarberg, BH
McLean, MJ
机构
[1] Amer Society Pain Educators, Montclair, NJ 07042 USA
[2] Univ Minnesota, Med Ctr, Pain & Palliat Care Ctr, Minneapolis, MN 55455 USA
[3] Kaiser Permanente, Chron Pain Management Program, San Diego, CA USA
[4] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA
关键词
D O I
10.1016/S0025-6196(11)61476-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Three case reports in this article Illustrate the diagnostic methods used and the treatment course encountered for many patients with diabetic peripheral neuropathic pain (DPNP). Each case addresses an aspect of DPNP: pain that appears to be refractory to initial therapy, DPNP occurring with other medical conditions, and nondiabetic neuropathy occurring in patients with diabetes mellitus. Together, these cases bring clarity to the confusing clinical experience for patients who have decreased sensation in combination with burning pain, and they apply the consensus guidelines for DPNP. Recently approved medications by the Food and Drug Administration for the treatment of DPNP offer hope for many patients whose pain was thought to be refractory to treatment.
引用
收藏
页码:S26 / S32
页数:7
相关论文
共 50 条
  • [1] Diabetic Peripheral Neuropathy and the Management of Diabetic Peripheral Neuropathic Pain
    Morales-Vidal, Sarkis
    Morgan, Christopher
    McCoyd, Mathew
    Hornik, Alejandro
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 145 - 153
  • [2] Treating Diabetic Peripheral Neuropathic Pain
    Lindsay, Tammy J.
    Rodgers, Blake C.
    Savath, Vincent
    Hettinger, Kevin
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (02) : 151 - 158
  • [3] Diabetic peripheral neuropathic pain: Recognition and management
    Cole, B. Eliot
    PAIN MEDICINE, 2007, 8 : S27 - S32
  • [4] Pharmacologic management of diabetic peripheral neuropathic pain
    Iyer, Shridhar
    Tanenberg, Robert J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (13) : 1765 - 1775
  • [5] Fulranumab for treatment of diabetic peripheral neuropathic pain
    Wang, Hao
    Romano, Gary
    Frustaci, Mary Ellen
    Bohidar, Norm
    Ma, Huizhong
    Sanga, Panna
    Ness, Seth
    Russell, Lucille J.
    Fedgchin, Margaret
    Kelly, Kathleen M.
    Thipphawong, John
    NEUROLOGY, 2014, 83 (07) : 628 - 637
  • [6] Duloxetine in the management of diabetic peripheral neuropathic pain
    Ormseth, Michelle J.
    Scholz, Beth A.
    Boomershine, Chad S.
    PATIENT PREFERENCE AND ADHERENCE, 2011, 5 : 343 - 356
  • [7] Diabetic Peripheral Neuropathic Pain: Is Gabapentin Effective?
    Hyatt, Joel D.
    Daniel, Dale
    Tran, Quynhlam V.
    Millares, Mirta
    Kubota, Debbie R.
    AMERICAN FAMILY PHYSICIAN, 2011, 84 (05) : 480 - 482
  • [8] Cymbalta approved for diabetic peripheral neuropathic pain
    不详
    DRUG NEWS & PERSPECTIVES, 2004, 17 (07) : 487 - 487
  • [9] Duloxetine in the treatment of diabetic peripheral neuropathic pain
    Goldstein, David J.
    FUTURE NEUROLOGY, 2006, 1 (06) : 700 - 711
  • [10] Emerging drugs for diabetic peripheral neuropathy and neuropathic pain
    Papanas, Nikolaos
    Ziegler, Dan
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (04) : 393 - 407